[1]Huang, C., Huang, L., Wang, Y., Li, X., Ren, L., & Gu, X. et al. (2021). 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. The Lancet, 397(10270), 220-232. doi: 10.1016/s0140-6736(20)32656-8
[2]Huang, L., Li, X., Gu, X., Zhang, H., Ren, L., & Guo, L. et al. (2022). Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. The Lancet Respiratory Medicine, 10(9), 863-876. doi: 10.1016/s2213-2600(22)00126-6
[3]Salari, N., Khodayari, Y., Hosseinian-Far, A., Zarei, H., Rasoulpoor, S., Akbari, H., & Mohammadi, M. (2022). Global prevalence of chronic fatigue syndrome among long COVID-19 patients: A systematic review and meta-analysis. Biopsychosocial Medicine, 16(1). doi: 10.1186/s13030-022-00250-5
[4]DOJ and HHS Issue Guidance on ‘Long COVID’ and Disability Rights Under the ADA, Section 504, and Section 1557. (2021b, August 9). https://www.justice.gov/opa/pr/doj-and-hhs-issue-guidance-long-covid-and-disability-rights-under-ada-section-504-and-section
[5]Bansal, R., Gubbi, S., & Koch, C. (2022). COVID-19 and chronic fatigue syndrome: An endocrine perspective. Journal Of Clinical &Amp; Translational Endocrinology, 27, 100284. doi: 10.1016/j.jcte.2021.100284
[6]Paul, B. D., Lemle, M. D., Komaroff, A. L., & Snyder, S. H. (2021). Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proceedings of the National Academy of Sciences, 118(34). https://doi.org/10.1073/pnas.2024358118
[7]Azcue, N., Gómez-Esteban, J., Acera, M., Tijero, B., Fernandez, T., & Ayo-Mentxakatorre, N. et al. (2022). Brain fog of post-COVID-19 condition and Chronic Fatigue Syndrome, same medical disorder?. Journal Of Translational Medicine, 20(1). doi: 10.1186/s12967-022-03764-2
[8]Leong, K., Yip, H., Kuo, C., & Tsai, S. (2022). Treatments of chronic fatigue syndrome and its debilitating comorbidities: a 12-year population-based study. Journal Of Translational Medicine, 20(1). doi: 10.1186/s12967-022-03461-0
[9]APA PsycNet. (2023). Retrieved 3 January 2023, from https://psycnet.apa.org/doiLanding?doi=10.1037%2F1076-8998.5.4.411
[10]Myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS) - Diagnosis . (2018). Retrieved 3 January 2023, from https://www.nhs.uk/conditions/chronic-fatigue-syndrome-cfs/diagnosis/
[11]Kjellberg, A., Abdel-Halim, L., Hassler, A., El Gharbi, S., Al-Ezerjawi, S., & Boström, E. et al. (2022). Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): protocol for a randomised, placebo-controlled, double-blind, phase II clinical trial. BMJ Open, 12(11), e061870. doi: 10.1136/bmjopen-2022-061870
[12]Hidaka, T., Fujii, K., Funahashi, I., Fukutomi, N., & Hosoe, K. (2008). Safety assessment of coenzyme Q10 (CoQ10). BioFactors (Oxford, England), 32(1-4), 199–208. https://doi.org/10.1002/biof.5520320124
[13]Barletta, M. A., Marino, G., Spagnolo, B., Bianchi, F. P., Falappone, P. C. F., Spagnolo, L., & Gatti, P. (2022). Coenzyme Q10 + alpha lipoic acid for chronic COVID syndrome. Clinical and experimental medicine, 1–12. Advance online publication. https://doi.org/10.1007/s10238-022-00871-8
[14]Castro-Marrero, J., Segundo, M. J., Lacasa, M., Martinez-Martinez, A., Sentañes, R. S., & Alegre-Martin, J. (2021). Effect of Dietary Coenzyme Q10 Plus NADH Supplementation on Fatigue Perception and Health-Related Quality of Life in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients, 13(8), 2658. https://doi.org/10.3390/nu13082658
[15]Castro-Marrero, J., Domingo, J. C., Cordobilla, B., Ferrer, R., Giralt, M., Sanmartín-Sentañes, R., & Alegre-Martín, J. (2022). Does Coenzyme Q10 Plus Selenium Supplementation Ameliorate Clinical Outcomes by Modulating Oxidative Stress and Inflammation in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?. Antioxidants & redox signaling, 36(10-12), 729–739. https://doi.org/10.1089/ars.2022.0018
[16]Teitelbaum, J. E., Johnson, C., & St Cyr, J. (2006). The use of D-ribose in chronic fatigue syndrome and fibromyalgia: a pilot study. Journal of alternative and complementary medicine (New York, N.Y.), 12(9), 857–862. https://doi.org/10.1089/acm.2006.12.857
[17]Sathyapalan, T., Beckett, S., Rigby, A., Mellor, D., & Atkin, S. (2010). High cocoa polyphenol rich chocolate may reduce the burden of the symptoms in chronic fatigue syndrome. Nutrition Journal, 9(1). doi: 10.1186/1475-2891-9-55
[18]Tosato, M., Calvani, R., Picca, A., Ciciarello, F., Galluzzo, V., Coelho-Júnior, H. J., Di Giorgio, A., Di Mario, C., Gervasoni, J., Gremese, E., Leone, P. M., Nesci, A., Paglionico, A. M., Santoliquido, A., Santoro, L., Santucci, L., Tolusso, B., Urbani, A., Marini, F., Marzetti, E., … Gemelli against COVID-19 Post-Acute Care Team (2022). Effects of l-Arginine Plus Vitamin C Supplementation on Physical Performance, Endothelial Function, and Persistent Fatigue in Adults with Long COVID: A Single-Blind Randomized Controlled Trial. Nutrients, 14(23), 4984. https://doi.org/10.3390/nu14234984
[19]Ostojic, S., Stojanovic, M., Drid, P., Hoffman, J., Sekulic, D., & Zenic, N. (2016). Supplementation with Guanidinoacetic Acid in Women with Chronic Fatigue Syndrome. Nutrients, 8(2), 72. doi: 10.3390/nu8020072
[20]Strayer, D., Young, D., & Mitchell, W. (2020). Effect of disease duration in a randomized Phase III trial of rintatolimod, an immune modulator for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. PLOS ONE, 15(10), e0240403. doi: 10.1371/journal.pone.0240403
[21]Vahradyan, A. (2022). Breaking News: FDA clears Ampligen to start a clinical trial in Long Covid - Solve ME/CFS Initiative. Retrieved 3 January 2023, from https://solvecfs.org/breaking-news-fda-clears-ampligen-to-start-a-clinical-trial-in-long-covid/
